Table 2.
Baseline characteristics for survivors and non-survivors.
| Survivors | Non-survivors | p-value | |
|---|---|---|---|
| N | 304 | 87 | |
| Age, years | 56.2 ± 12.1 | 60.6 ± 10.9 | 0.001* |
| Male | 236 (77.6) | 75 (86.2) | 0.080 |
| Current smoker | 164 (53.9) | 50 (57.5) | 0.580 |
| Hypertension | 246 (80.9) | 73 (83.9) | 0.236 |
| Diabetes | 18 (5.9) | 2 (2.3) | 0.269 |
| COPD | 10 (3.3) | 8 (9.2) | 0.038* |
| Hyperlipidemia | 17 (5.6) | 1 (1.1) | 0.141 |
| SBP, mmHg | 147.2 ± 26.2 | 148.5 ± 26.7 | 0.491 |
| DBP, mmHg | 84.8 ± 25.9 | 84.5 ± 15.0 | 0.410 |
| WBC, ×1012/L | 9.8 ± 3.5 | 9.7 ± 4.0 | 0.524 |
| RBC, ×1012/L | 4.3 ± 0.6 | 4.0 ± 0.6 | 0.000* |
| Hb, g/dl | 12.8 ± 1.9 | 12.0 ± 1.9 | 0.000* |
| Platelet, ×109/L | 174.0 (134.0–226.3) | 146.5 (114.5–229.5) | 0.020* |
| LDH, U/L | 196.0 (168.3–231.7) | 204.3 (179.6–260.6) | 0.095 |
| Albumin, g/L | 39.9 ± 5.2 | 39.1 ± 4.7 | 0.119 |
| Creatinine, μmol/L | 78.2 (63.9–96.7) | 82.1 (62.7–120.4) | 0.124 |
| Cystatin C, mg/L | 0.97 (0.80–1.17) | 1.09 (0.90–1.49) | 0.004* |
| Urea nitrogen, mmol/L | 6.7 ± 3.1 | 7.5 ± 3.1 | 0.024* |
| LDL-C, mmol/L | 2.7 ± 0.8 | 2.3 ± 0.8 | 0.000* |
| Total cholesterol, mmol/L | 4.3 ± 0.9 | 3.9 ± 1.5 | 0.000* |
Continuous values are documented by mean ± SD or median (1st quartile−3rd quartile). Categorical variables are recorded by n (percentage).
SBP, systolic blood pressure; DBP, diastolic blood pressure; RBC, red blood cell count; COPD, chronic obstructive pulmonary disease; Hb, hemoglobin; LDH, lactate dehydrogenase; LDL-C, low-density lipoprotein-cholesterol; WBC, white blood (cell) count.
*
p < 0.05.